[{"bbox": [90, 101, 368, 132], "category": "Page-header", "text": "Q-Line Biotech Limited"}, {"bbox": [90, 170, 1604, 235], "category": "List-item", "text": "6. Except as mentioned in 2 (a) (vii) and (viii) above, no Equity Shares have been issued at price below the Issue price within last one year from the date of the Draft Red Herring Prospectus."}, {"bbox": [90, 267, 1314, 300], "category": "List-item", "text": "7. **Details of Allotment made in the last two years preceding the date of Draft Red Herring Prospectus**"}, {"bbox": [90, 330, 1608, 395], "category": "Text", "text": "Except as mentioned in point 2 (a) (vii) and (viii) above, we have not issued any Equity Share in the last two years preceding the date of Draft Red Herring Prospectus."}, {"bbox": [90, 422, 1604, 623], "category": "Table", "text": "<table><thead><tr><td>Date of Allotment</td><td>Number of Equity Shares</td><td>Face Value (Rs.)</td><td>Issue Price (Rs.)</td><td>Reasons for Allotment</td><td>Name of Allottees</td></tr></thead><tbody><tr><td>August 28, 2025</td><td>1,41,75,000</td><td>10/-</td><td>-</td><td>Bonus Issue in the ratio of 9:1</td><td>Refer table 2 (a) (vii) above</td></tr><tr><td>September 27, 2025</td><td>5,24,999</td><td>10/-</td><td>10/-</td><td>Right Issue</td><td>Refer table 2 (a) (viii) above</td></tr></tbody></table>"}, {"bbox": [90, 655, 1606, 717], "category": "List-item", "text": "8. We have not revalued our assets since inception and have not issued any Equity Shares (including bonus shares) by capitalizing any revaluation reserves."}, {"bbox": [90, 720, 1487, 784], "category": "List-item", "text": "9. The issuer company is in compliance with the Companies Act, 2013 with respect to issuance of securities since inception till the date of filing of Drat Red Herring Prospectus."}, {"bbox": [833, 2032, 862, 2061], "category": "Page-footer", "text": "75"}]